The report describes the U.S. pharmaceutical supply chain, following prescription drugs as they move from manufacturers, to wholesale distributors, to pharmacies, and ultimately to patients. The report describes both the physical distribution of drugs through the chain, as well as the flow of money and the financial relationships among the key players. It was prepared for the Foundation by Dan Mendelson and The Health Strategies Consultancy.

 Report (.pdf)